IL33 and colitis: Others have reported that there are differences in the gut microbiomes of IL-33−/− versus WT mice and that cohousing WT and IL-33−/− mice reduces differences in their gut microbiomes and ablates IL-33-dependent differences in susceptibility to colitis in these mice [31].